SUMOylation and Major Depressive Disorder |
| |
| Authors: | Seok-Won Jeoung Hyun-Sun Park Zae Young Ryoo Dong-Hyung Cho Hyun-Shik Lee Hong-Yeoul Ryu |
| |
| Affiliation: | 1.BK21 FOUR KNU Creative BioResearch Group, School of Life Sciences, College of National Sciences, Kyungpook National University, Daegu 41566, Korea; (S.-W.J.); (Z.Y.R.); (D.-H.C.); (H.-S.L.);2.Brain Science and Engineering Institute, Kyungpook National University, Daegu 41566, Korea;3.Department of Biochemistry, Inje University College of Medicine, Busan 50834, Korea; |
| |
| Abstract: | Since the discovery of the small ubiquitin-like modifier (SUMO) protein in 1995, SUMOylation has been considered a crucial post-translational modification in diverse cellular functions. In neurons, SUMOylation has various roles ranging from managing synaptic transmitter release to maintaining mitochondrial integrity and determining neuronal health. It has been discovered that neuronal dysfunction is a key factor in the development of major depressive disorder (MDD). PubMed and Google Scholar databases were searched with keywords such as ‘SUMO’, ‘neuronal plasticity’, and ‘depression’ to obtain relevant scientific literature. Here, we provide an overview of recent studies demonstrating the role of SUMOylation in maintaining neuronal function in participants suffering from MDD. |
| |
| Keywords: | SUMOylation major depressive disorder (MDD) neuron synapse mitochondria |
|
|
